Mark S. Gold

Gold’s research has focused on the mechanisms underlying opioid addiction, particularly the role of the locus coeruleus in dependence and withdrawal, contributing to treatment methods developed in 1978. He contributed to the use of opioid antagonists, such as naltrexone, in treating opioid addiction and helped develop treatment strategies for substances including cocaine, methamphetamine, and alcohol. His research on dopamine’s role in addiction extended to compulsive behaviors like overeating and gambling, examining links between substance addiction and behavioral compulsions. His work also contributed to the concept of food addiction, especially regarding highly processed, high-fat, and high-sugar foods. Provided by Wikipedia
Showing 1 - 20 results of 26 for search 'Mark S. Gold', query time: 0.06s
Refine Results
-
1
A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder by Muhammet Celik, Mark S. Gold, Brian Fuehrlein
Published 2024-03-01
Article -
2
Dopamine and glucose, obesity and Reward Deficiency Syndrome by Kenneth eBlum, (Peter) Panayotis K. Thanos, Mark Stephen Gold
Published 2014-09-01
Article -
3
Opioid use disorder: current trends and potential treatments by Yu Kyung Lee, Mark S. Gold, Kenneth Blum, Panayotis K. Thanos, Colin Hanna, Brian S. Fuehrlein
Published 2024-01-01
Article -
4
-
5
The Next Generation of Obesity Treatments: Beyond Suppressing Appetite by Nicole M Avena, Nicole M Avena, Susan eMurray, Susan eMurray, Mark S Gold
Published 2013-10-01
Article -
6
-
7
-
8
-
9
-
10
Systematic evaluation of "compliance" to prescribed treatment medications and "abstinence" from psychoactive drug abuse in chemical dependence programs: data from the comprehensive... by Kenneth Blum, David Han, John Femino, David E Smith, Scott Saunders, Thomas Simpatico, Stephen J Schoenthaler, Marlene Oscar-Berman, Mark S Gold
Published 2014-01-01
Article -
11
Fatty Acid-Binding Protein 5 Gene Deletion Enhances Nicotine-Conditioned Place Preference: Illuminating the Putative Gateway Mechanisms by Nicole Roeder, Brittany Richardson, Abrianna Mihalkovic, Samantha Penman, Olivia White, John Hamilton, Ashim Gupta, Kenneth Blum, Mark S. Gold, Panayotis K. Thanos
Published 2023-01-01
Article -
12
-
13
Evoked Potentials and Memory/Cognition Tests Validate Brain Atrophy as Measured by 3T MRI (NeuroQuant) in Cognitively Impaired Patients. by Eric R Braverman, Kenneth Blum, Karl L Hussman, David Han, Kristina Dushaj, Mona Li, Gabriela Marin, Rajendra D Badgaiyan, Richard Smayda, Mark S Gold
Published 2015-01-01
Article -
14
-
15
Substance Use Disorders and Behavioral Addictions During the COVID-19 Pandemic and COVID-19-Related Restrictions by Nicole M. Avena, Nicole M. Avena, Julia Simkus, Anne Lewandowski, Mark S. Gold, Marc N. Potenza, Marc N. Potenza, Marc N. Potenza, Marc N. Potenza
Published 2021-04-01
Article -
16
Fatty acid binding protein 7 plays an important modulatory sex-dependent role on brain endocannabinoid levels and THC metabolism. by Samantha L Penman, Alexandria S Senetra, Nicole M Roeder, Brittany J Richardson, Ojas Pareek, Yuji Owada, Yoshiteru Kagawa, Mark S Gold, Christopher R McCurdy, Abhisheak Sharma, Panayotis K Thanos
Published 2024-01-01
Article -
17
Fatty acid binding protein 7 plays an important modulatory sex-dependent role on brain endocannabinoid levels and THC metabolism by Samantha L. Penman, Alexandria S. Senetra, Nicole M. Roeder, Brittany J. Richardson, Ojas Pareek, Yuji Owada, Yoshiteru Kagawa, Mark S. Gold, Christopher R. McCurdy, Abhisheak Sharma, Panayotis K. Thanos
Published 2024-01-01
Article -
18
Enhanced functional connectivity and volume between cognitive and reward centers of naïve rodent brain produced by pro-dopaminergic agent KB220Z. by Marcelo Febo, Kenneth Blum, Rajendra D Badgaiyan, Pablo D Perez, Luis M Colon-Perez, Panayotis K Thanos, Craig F Ferris, Praveen Kulkarni, John Giordano, David Baron, Mark S Gold
Published 2017-01-01
Article -
19
Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mec... by Marjorie C. Gondré-Lewis, Igor Elman, Tanya Alim, Edwin Chapman, Beverlyn Settles-Reaves, Carine Galvao, Mark S. Gold, David Baron, Shan Kazmi, Eliot Gardner, Ashim Gupta, Catherine Dennen, Kenneth Blum
Published 2022-04-01
Article -
20
Prevalence of drug and alcohol use in urban Afghanistan: epidemiological data from the Afghanistan National Urban Drug Use Study (ANUDUS) by Dr. Linda B Cottler, PhD, Shaun Ajinkya, MPH, Bruce A Goldberger, PhD, Mohammad Asrar Ghani, MD, David M Martin, PhD, Hui Hu, BS, Mark S Gold, MD
Published 2014-10-01
Article